The biotechnology market in Asia-Pacific region looks very lucrative from investment perspective as it has enjoyed double-digit growth in past few years. The industry is attracting more and more private investments in wake of immense growth opportunities and vast untapped biotech markets. Identifying the future growth potential of the industry, the governments of different countries in the Asia-Pacific region are taking up various initiatives to promote research in the region. Overall, the Asia-Pacific biotech market is expected to spur future growth in the global biotechnology market.
According to our new research report, “Asia Pacific Biotechnology Market (2008-2012)”, the Asia-Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012. Currently, the industry is driven by new developing markets like Malaysia and India where developments in the sector are on a full swing. Anticipating the future growth, governments are promoting the industry by making investments and implementing new strategies.
Our research has found that Japan and China are dominating the industry. While higher growth rate has been witnessed in emerging markets like Malaysia, Japan and China are anticipated to dominate the market in future with combined share of around 70% of overall market. In this regard, our report provides rational analysis of various factors which will drive this market over the forecast period.
The report also provides extensive information and data of the biotech market in the Asia-Pacific region as well as discusses the emerging trends like contract research and manufacturing, bioinformatics, generics market etc. It provides valuable information to pharmaceutical & biotechnology companies and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets. The report also contains detailed analysis and statistics of the market size, growth, share, segmentation, geographic distribution and trends in technology development.
.jpg)
